Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7271149 GLP-1 fusion proteins

Patent 7271149 was granted and assigned to Eli Lilly on September, 2007 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Eli Lilly
Eli Lilly
Date Filed
November 29, 2001
Date of Patent
September 18, 2007
Patent Application Number
10433108
Patent Citations Received
‌
US Patent 12116400 Albumin variants and conjugates
0
‌
US Patent 12059452 Fusion proteins
0
‌
US Patent 12083169 Alkaline phosphatase polypeptides and methods of use thereof
0
‌
US Patent 11759503 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759502 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759501 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11780882 Peptide compounds and peptide conjugates for the treatment of cancer through receptor-mediated chemotherapy
‌
US Patent 11788066 Antibody conjugates and methods of making and using the same
‌
US Patent 11833248 Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
0
‌
US Patent 11890325 Therapeutic uses of dulaglutide
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7271149
Patent Primary Examiner
‌
Robert A Wax

Find more entities like US Patent 7271149 GLP-1 fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo